NEW YORK (GenomeWeb) – KeyGene announced today that it has licensed its proprietary sequence-based genotyping (SBG) technology to the University of Wisconsin-Madison.

The technology allows for genome-wide SNP discovery and genotyping in large populations of organisms in a single experiment. Under the terms of the deal, UW-Madison will be able to offer SBG services in all species to its research collaborators and clients worldwide. Additional terms were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.